本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Adverum Biotechnologies, Inc.

2.70
+0.03001.12%
盘后2.58-0.1200-4.44%19:41 EDT
成交量:6.30万
成交额:16.93万
市值:5,640.50万
市盈率:-0.37
高:2.75
开:2.69
低:2.61
收:2.67
数据加载中...
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/30

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/27

SEC问询函

Form CORRESP - Correspondence
2024/03/20

重要事件披露

Form 8-K - Current report
2024/03/19

SEC问询函

Form CORRESP - Correspondence
2024/03/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report